Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1996 1
1998 1
2000 1
2001 2
2005 2
2006 2
2007 2
2008 8
2009 5
2010 7
2011 10
2012 9
2013 6
2014 9
2015 6
2016 18
2017 26
2018 34
2019 40
2020 44
Text availability
Article attribute
Article type
Publication date

Search Results

219 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for baoding cheng
Search for Baodong Cheng instead (1 results)
NIK signaling axis regulates dendritic cell function in intestinal immunity and homeostasis.
Jie Z, Yang JY, Gu M, Wang H, Xie X, Li Y, Liu T, Zhu L, Shi J, Zhang L, Zhou X, Joo D, Brightbill HD, Cong Y, Lin D, Cheng X, Sun SC. Jie Z, et al. Nat Immunol. 2018 Nov;19(11):1224-1235. doi: 10.1038/s41590-018-0206-z. Epub 2018 Sep 24. Nat Immunol. 2018. PMID: 30250187 Free PMC article.
Recent advances in microRNA detection.
Cheng Y, Dong L, Zhang J, Zhao Y, Li Z. Cheng Y, et al. Analyst. 2018 Apr 16;143(8):1758-1774. doi: 10.1039/C7AN02001E. Analyst. 2018. PMID: 29560992 Review.
Dysregulation of DPP4 Is Associated with the AMPK/JAK2/STAT3 Pathway in Adipocytes Under Insulin Resistance Status and Liraglutide Intervention.
Cheng F, Yuan G, He J, Shao Y, Zhang J, Guo X. Cheng F, et al. Diabetes Metab Syndr Obes. 2019 Dec 11;12:2635-2644. doi: 10.2147/DMSO.S229838. eCollection 2019. Diabetes Metab Syndr Obes. 2019. PMID: 31849507 Free PMC article.
[Inhibitors of JAK2/STAT Signaling Pathway and Hematologic Malignancies-Review].
Zhao YL, Liu GM, Zhang LJ, Liang WT, Cheng ZY. Zhao YL, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Aug;24(4):1275-9. doi: 10.7534/j.issn.1009-2137.2016.04.059. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016. PMID: 27531815 Review. Chinese.
MicroRNA-575 regulates development of gastric cancer by targeting PTEN.
Wang YN, Xu F, Zhang P, Wang P, Wei YN, Wu C, Cheng SJ. Wang YN, et al. Biomed Pharmacother. 2019 May;113:108716. doi: 10.1016/j.biopha.2019.108716. Epub 2019 Mar 4. Biomed Pharmacother. 2019. PMID: 30844657 Free article.
TBK-binding protein 1 regulates IL-15-induced autophagy and NKT cell survival.
Zhu L, Xie X, Zhang L, Wang H, Jie Z, Zhou X, Shi J, Zhao S, Zhang B, Cheng X, Sun SC. Zhu L, et al. Nat Commun. 2018 Jul 18;9(1):2812. doi: 10.1038/s41467-018-05097-5. Nat Commun. 2018. PMID: 30022064 Free PMC article.
[Review on photoacoustic tomographic image reconstruction for acoustically heterogeneous tissues].
Duan S, Sun Z. Duan S, et al. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2019 Jun 25;36(3):486-492. doi: 10.7507/1001-5515.201809014. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2019. PMID: 31232553 Review. Chinese.
Antibody-Armed Platelets for the Regenerative Targeting of Endogenous Stem Cells.
Shen D, Li Z, Hu S, Huang K, Su T, Liang H, Liu F, Cheng K. Shen D, et al. Nano Lett. 2019 Mar 13;19(3):1883-1891. doi: 10.1021/acs.nanolett.8b04970. Epub 2019 Feb 18. Nano Lett. 2019. PMID: 30775924 Free PMC article.
Preventing abnormal NF-κB activation and autoimmunity by Otub1-mediated p100 stabilization.
Li Y, Yang JY, Xie X, Jie Z, Zhang L, Shi J, Lin D, Gu M, Zhou X, Li HS, Watowich SS, Jain A, Yun Jung S, Qin J, Cheng X, Sun SC. Li Y, et al. Cell Res. 2019 Jun;29(6):474-485. doi: 10.1038/s41422-019-0174-3. Epub 2019 May 13. Cell Res. 2019. PMID: 31086255 Free PMC article.
Routine-Dose and High-Dose Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Exon 21-L858R Mutation: the Randomized, Phase II, INCREASE Trial.
Li X, Zhang L, Jiang D, Wang Y, Zang A, Ding C, Zhao M, Su W, Zhang Y, Zhong D, Wu J, Zhang C, An G, Hu X, Cheng G, Wang H, Li Y, He X, Liu J, Liang L, Ding L, Mao L, Zhang S. Li X, et al. Clin Cancer Res. 2020 Jul 1;26(13):3162-3171. doi: 10.1158/1078-0432.CCR-19-3064. Epub 2020 Feb 14. Clin Cancer Res. 2020. PMID: 32060099 Free article.
219 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback